fp

FP-biotin is a potent organophosphorus toxicant ideal for identifying novel biomarkers of organophosphorus exposure. It measures FAAH, ABHD6, and MAG-lipase activity specifically in plasma studies, thanks to the efficient purification of biotinylated peptides through binding to immobilized avidin beads.

FP-21399, an HIV fusion inhibitor, is used potentially for the treatment of HIV infection.

FPL-62129 is a calcium channel antagonist and a novel angiotensin-converting enzyme inhibitor with vasodilator activity for the study of cardiovascular disease.

FPL 55712 is a leukotriene receptor and SRS-A antagonist that inhibits bronchoconstriction and can be used in studies of asthma and coronary artery thrombosis.

DFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor, with an IC50 of approximately 0.1-0.4 μM for both mouse and human AQP3. It demonstrates selectivity for AQP3 compared to homologous AQP subtypes AQP7 and AQP9.

(2RS)-FPMPA（FPMPA） has antiviral activity with an IC50 value of 1.85 μM measured in human MT12 cells infected with SHIV (DH4R).

FPMPA PM is a derivative of FPMPA, a selective adenosine A3 receptor agonist with anti-inflammatory, analgesic and neuroprotective activities.

Cefpodoxime is an oral third generation cephalosporin antibiotic. It is active against most Gram positive and Gram negative bacteria. It is commonly used to treat acute otitis media, pharyngitis, and sinusitis. Cefpodoxime proxetil is a prodrug which is a

L-4FPG is a Glycine derivative, inhibits the neutral amino acid transporters ASCT1 and ASCT2.

Cefpiramide acid (Cefpiramidum) is a third-generation cephalosporin antibiotic.

Cefpirome sulfate (HR-810 sulfate) is a fourth-generation cephalosporin antibiotic.

BVFP is a PGRN-SORT1 inhibitor SORT1 antagonist that binds to key residues 588-593 of PGRN, a multifunctional secreted glycoprotein, and SORT1, a neuronal receptor for PGRN.BVFP is able to block PGRN-SORT1 binding, restore extracellular levels of PGRN , inhibits SORT1-mediated rPGRN endocytosis, and has therapeutic potential for frontotemporal lobe dementia (FTLD-TDP).

FPL64176 is a L-type calcium channels activator.

FPS-ZM1 is a high-affinity, RAGE-specific inhibitor that obstructs Aβ binding to the V domain of RAGE.

FPR A14 is an agonist of formyl peptide receptor (FPR) and induces cell differentiation.

FPI-1523 sodium, a derivative of avibactam, is a potent β-lactamase inhibitor with Kd values of 4 nM and 34 nM for CTX-M-15 and OXA-48, respectively. It inhibited PBP2 with an IC50 of 3.2 μM and has a high level of antibacterial and considerable antimicrobial activity.

FPL 62064 is a potent dual inhibitor of 5-lipoxygenase (5-LOX) and COX (IC50 of 3.5 μM and 3.1 μM for RBL-1 cytosolic 5-lipoxygenase and prostaglandin synthetase, respectively).

Cefprozil monohydrate (Cefprozil) is a second-generation cephalosporin-type antibiotic.

FPH1 (BRD-6125) (BRD-6125) can promote the expansion of iPS-derived hepatocytes.

Sofpironium bromide (BBI4000) belongs to a class of drugs called anticholinergics, which exert their effect by blocking the action of acetylcholine.

Notoginsenoside FP2 is a natural product isolated from the fruit pedicels of Panax notoginseng and can be used in studies about the treatment of cardiovascular diseases.

FP0429 is an agonist of mGlu4.

NCFP is a mGlu5 positive allosteric modulator. It positively modulates mGlu5 without the induction of long-term potentiation and long-term depression in the hippocampus.

Diketone-PEG11-PFP ester serves as a PEG-based PROTAC linker for PROTAC synthesis[1].